FDA
-
-
-
-
-
-
-
Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead
-
-
-
-
-
-
-
Turn Therapeutics Appoints Veteran Capital Markets Executive Andrew Scott as Vice President of Corporate Communications
-
-
-
-
-
-
-
Turn Therapeutics to Commence Trading Today on Nasdaq
330,725 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

